Lundbeck Inc.

Lundbeck Inc.

Lundbeck Inc. (formerly Ovation Pharmaceuticals) hopes to earn its applause by staying on the look-out for niche pharmaceuticals that larger drugmakers cast aside. The company's focus is on developing drugs for central nervous system (CNS) disorders, as well as cancer drugs and hospital-based therapies. Its FDA-approved products for neurological conditions include treatments for ADHD, anxiety, and seizures; the company has several CNS products in its development pipeline, such as epilepsy drugs, drug addiction therapies, and seizure medications. Among its other marketed products are several oncology drugs, as well as a treatment for lead poisoning. The company was acquired by Denmark-based H. Lundbeck in 2009.

Contact Details

Office Address

Lundbeck Inc.
Four Parkway North, Suite 200
Deerfield, IL, USA 60015
Phone: (866) 337-6996
Fax: (847) 282-1001

Executives

Chairman

Wilbur H. (Bill) Gantz

CEO

Sean Nolan

Business Reviews for Lundbeck Inc.

Related Companies